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Abstract
Identification and characterization of anti-pathogenic agents from marine bacteria

The thesis entitled ‘Identification and characterization of anti-pathogenic agents from marine bacteria’ documents the hidden potentials of marine bacteria like the antibiofilm, anti-quorum sensing and anti-virulence properties. Since resistance to antibiotics is the striking factor that predisposes therapeutic breakdown and subsequent increase in morbidity and mortality, novel targets like biofilms, cell to cell communication (quorum sensing, QS) and production of virulence factors are of prime interest and are targeted for the development of novel drugs.  These phenotypes were shown crucial for the virulence and pathogenesis of the bacterial or fungal pathogens, besides it is widely believed that targeting these phenotypes will not let the pathogen to develop resistance. Epibiotic bacteria were explicitly studied knowing their defensive role in protecting the host from invading pathogens.  Bacteria associated with marine ecosystem are reported to play such a defensive role since the ecosystem is highly populated and a constant rivalry between the organisms takes place for nutrients, space, etc.  The potential of such bacteria to inhibit other bacteria were exploited to inhibit human bacterial and fungal pathogens.
	Marine samples like sediment, mangrove rhizosphere soil, sea water, sea grass and sea weed were collected from the Karankadu mangrove forest region in Palk Bay and 149 morphologically distinct bacteria were isolated from them.  Nineteen morphologically different bacteria isolated from coral mucus of Acropora digitifera in an earlier study were taken from the laboratory’s culture collection repository, Biobank.  All the marine bacteria were primarily screened for their ability to inhibit QS in an indicator bacterium, Chromobacterium violaceum ATCC12472.  Nine coral associated bacteria and 37 other bacteria from Karankadu region were found to possess anti-QS activity and are further studied against Staphylococcus aureus, S. epidermidis, Pseudomonas aeruginosa, Serratia marcescens, Candida albicans and C. tropicalis which play a crucial role in nosocomial and device associated infections in human.
	A coral associated actinomycete CAA-3, identified as Streptomyces akiyoshiensis, displayed potential antibiofilm activity against S. aureus, its clinical isolates and its drug resistant counterpart, Methicillin Resistant S. aureus (MRSA).  Another actinomycete (G9d) isolated from the seaweed Gracilaria gracilis, identified as Kocuria marina significantly inhibited the production of extracellular polymeric substance (EPS) production and biofilm formation in S. epidermidis. Two other coral associated bacteria called Delftia tsuruhatensis (CAB23) and Stenotrophomonas maltophilia (CAB41) were found to inhibit the biofilms
P. aeruginosa and S. marcescens.  Apart from inhibiting the biofilms, the extracts of CAB23 and CAB41 effectively inhibited the production of QS regulated virulence factors like LasA protease, LasB elastase, protease, pyocyanin and pyoverdin in 
P. aeruginosa and prodigiosin, total protease, lipase and swarming motility in S. marcescens.  K. marina was also found to inhibit the biofilms of C. albicans and C. tropicalis.  The extract of K. marina inhibited the production of secreted aspartyl proteinase (SAP), a major virulence trait in C. tropicalis that plays a crucial role in host tissue damage and immune evasion.  Purification and structural characterization of the active principles revealed the presence of Perfluoroeicosane in a fraction active against S. epidermidis and Gancidin W in a fraction active against C. tropicalis.
	On the whole, the study explains the potential of marine bacteria with special reference to actinomycetes as a potential source for anti-pathogenic agents which could replace the antibiotics in treatment of infectious diseases.  Further, this study unveils various leads for future research which will deliver fruitful products for use in the field of medicine.


